Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025

Core Viewpoint - Hyperion DeFi, Inc. is transitioning from a digital ophthalmic tech company to the first publicly-listed U.S. firm focused on building a strategic treasury around its native token HYPE, leveraging decentralized finance opportunities [1][5]. Group 1: Corporate Update Event - A special corporate update event is scheduled for July 29, 2025, featuring CIO Hyunsu Jung and CEO Michael Rowe to discuss the company's transformation and future strategies [1][2]. - The event will showcase how Hyperion DeFi is utilizing blockchain-native assets like HYPE to create scalable, yield-generating products and support the Hyperliquid ecosystem [2]. Group 2: Hyperliquid Platform and HYPE Token - Hyperliquid is a layer one blockchain optimized for high-frequency trading, featuring on-chain perpetual futures and spot order books with 70 millisecond block times [3]. - HYPE, the native token of Hyperliquid, offers utility through reduced trading fees and increased referral bonuses, with over 25 million HYPE sequestered as of June 2025, making it the 12th-largest cryptocurrency by market capitalization [4]. Group 3: Strategic Focus and Shareholder Benefits - Hyperion DeFi aims to provide shareholders with simplified access to the Hyperliquid ecosystem, focusing on long-term strategic treasury building with HYPE [5]. - The company is developing a proprietary Optejet User Filled Device (UFD) for ophthalmic applications, enhancing treatment compliance and outcomes [6]. Group 4: Investment Thesis and Future Strategies - The company believes in the potential of Hyperliquid as the future of decentralized finance and has accumulated over 1.4 million HYPE tokens to generate yield and secure the network [8]. - The investment thesis revolves around using a crypto treasury model to drive long-term shareholder value through staking revenues and ecosystem engagement [8].